Emil M deGoma

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc The evolution and refinement of traditional risk factors for cardiovascular disease
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Cardiol Rev 20:118-29. 2012
  2. doi request reprint A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman Center for Advanced Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104 Electronic address
    Acad Radiol 22:600-9. 2015
  3. pmc Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, PA, USA
    Atherosclerosis 229:517-23. 2013
  4. doi request reprint Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equations
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, PA, USA
    Atherosclerosis 227:172-7. 2013
  5. pmc Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Perelman Center for Advanced Medicine, Heart and Vascular Center, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Atherosclerosis 224:274-9. 2012
  6. doi request reprint The underappreciated impact of heart disease
    Emil M deGoma
    Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Womens Health Issues 20:299-303. 2010
  7. pmc Personalized vascular medicine: individualizing drug therapy
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, USA
    Vasc Med 16:391-404. 2011
  8. pmc Novel HDL-directed pharmacotherapeutic strategies
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Penn Tower, 6th Floor, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Nat Rev Cardiol 8:266-77. 2011
  9. doi request reprint Guidewire embolization and right ventricular perforation visualized by cardiac CT
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Cardiovasc Comput Tomogr 5:61-2. 2011
  10. pmc Targeting high density lipoproteins in the prevention of cardiovascular disease?
    Daniel B Larach
    Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 19104, USA
    Curr Cardiol Rep 14:684-91. 2012

Detail Information

Publications12

  1. pmc The evolution and refinement of traditional risk factors for cardiovascular disease
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Cardiol Rev 20:118-29. 2012
    ....
  2. doi request reprint A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman Center for Advanced Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104 Electronic address
    Acad Radiol 22:600-9. 2015
    ..We examined the effect of niacin on arterial (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT)...
  3. pmc Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, PA, USA
    Atherosclerosis 229:517-23. 2013
    ..It remains uncertain under which circumstances atherogenic lipoprotein enumeration such as LDL particle number (LDL-P) differs from simultaneously acquired non-HDL-C...
  4. doi request reprint Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equations
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, PA, USA
    Atherosclerosis 227:172-7. 2013
    ..However, the effect of these suggested thresholds of relative risk on absolute global risk remains uncertain...
  5. pmc Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Perelman Center for Advanced Medicine, Heart and Vascular Center, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Atherosclerosis 224:274-9. 2012
    ..We sought to compare the intraindividual variability of CRP with that of cholesterol measures using the multi-ethnic study of atherosclerosis (MESA)...
  6. doi request reprint The underappreciated impact of heart disease
    Emil M deGoma
    Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Womens Health Issues 20:299-303. 2010
    ....
  7. pmc Personalized vascular medicine: individualizing drug therapy
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, USA
    Vasc Med 16:391-404. 2011
    ..Translation to routine clinical practice awaits the results of ongoing randomized clinical trials comparing personalized approaches with standard of care management...
  8. pmc Novel HDL-directed pharmacotherapeutic strategies
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Penn Tower, 6th Floor, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Nat Rev Cardiol 8:266-77. 2011
    ....
  9. doi request reprint Guidewire embolization and right ventricular perforation visualized by cardiac CT
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Cardiovasc Comput Tomogr 5:61-2. 2011
    ....
  10. pmc Targeting high density lipoproteins in the prevention of cardiovascular disease?
    Daniel B Larach
    Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 19104, USA
    Curr Cardiol Rep 14:684-91. 2012
    ....
  11. doi request reprint Pharmacologic interactions of multidrug therapy for dyslipidemia
    Nidhi Mehta
    Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, 9 Gates Building 3400 Spruce Street, Philadelphia, PA 19103, USA
    Curr Atheroscler Rep 15:303. 2013
    ..In the past few years, several landmark trials have provided important information regarding the efficacy and safety of non-statin therapy for dyslipidemia and cardiovascular risk reduction...
  12. pmc Approach to the patient with extremely low HDL-cholesterol
    Daniel J Rader
    Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, 11 125 Translational Research Center, 3400 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA
    J Clin Endocrinol Metab 97:3399-407. 2012
    ..Uncommon encounters with patients exhibiting extremely low HDL-C provide an opportunity to directly observe the role of HDL metabolism in atherosclerosis and beyond the vascular system...